Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($) |
Preferred Stock [Member]
Series D Preferred Stock [Member]
|
Preferred Stock [Member]
Series D-1 Preferred Stock [Member]
|
Common Stock [Member] |
Additional Paid-in Capital [Member] |
AOCI Attributable to Parent [Member] |
Retained Earnings [Member] |
Noncontrolling Interest [Member] |
Total |
|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2024 | $ 957 | $ 13,106 | $ 420,280 | $ 251,090,027 | $ (60,741) | $ (257,422,961) | $ (9,893) | $ (5,969,225) |
| Balance, shares at Dec. 31, 2024 | 956,985 | 13,106,223 | 420,279,879 | |||||
| Issuance of common stock of majority-owned subsidiary | 634,782 | 65,218 | 700,000 | |||||
| Stock-based compensation: | ||||||||
| Amortization of stock options | 315,100 | 315,100 | ||||||
| Net loss | (1,140,108) | (21,494) | (1,161,602) | |||||
| Other comprehensive income | 52 | 52 | ||||||
| Conversion of 2022 Notes to Series D-1 Preferred Stock | $ 365 | 1,046,329 | 1,046,694 | |||||
| Conversion of 2022 Notes to Series D-1 Preferred Stock, shares | 365,400 | |||||||
| Balance at Mar. 31, 2025 | $ 957 | $ 13,471 | $ 420,280 | 253,086,238 | (60,689) | (258,563,069) | 33,831 | (5,068,981) |
| Balance, shares at Mar. 31, 2025 | 956,985 | 13,471,623 | 420,279,879 | |||||
| Balance at Dec. 31, 2024 | $ 957 | $ 13,106 | $ 420,280 | 251,090,027 | (60,741) | (257,422,961) | (9,893) | (5,969,225) |
| Balance, shares at Dec. 31, 2024 | 956,985 | 13,106,223 | 420,279,879 | |||||
| Stock-based compensation: | ||||||||
| Net loss | (3,013,683) | |||||||
| Balance at Jun. 30, 2025 | $ 957 | $ 13,724 | $ 420,280 | 254,131,964 | (60,361) | (260,377,489) | (3,830) | (5,874,755) |
| Balance, shares at Jun. 30, 2025 | 956,985 | 13,724,563 | 420,279,879 | |||||
| Balance at Mar. 31, 2025 | $ 957 | $ 13,471 | $ 420,280 | 253,086,238 | (60,689) | (258,563,069) | 33,831 | (5,068,981) |
| Balance, shares at Mar. 31, 2025 | 956,985 | 13,471,623 | 420,279,879 | |||||
| Stock-based compensation: | ||||||||
| Amortization of stock options | 322,070 | 322,070 | ||||||
| Net loss | (1,814,420) | (37,661) | (1,852,081) | |||||
| Other comprehensive income | 328 | 328 | ||||||
| Conversion of 2022 Notes to Series D-1 Preferred Stock | $ 253 | 723,656 | 723,909 | |||||
| Conversion of 2022 Notes to Series D-1 Preferred Stock, shares | 252,940 | |||||||
| Balance at Jun. 30, 2025 | $ 957 | $ 13,724 | $ 420,280 | 254,131,964 | (60,361) | (260,377,489) | (3,830) | (5,874,755) |
| Balance, shares at Jun. 30, 2025 | 956,985 | 13,724,563 | 420,279,879 | |||||
| Balance at Dec. 31, 2025 | $ 957 | $ 14,183 | $ 420,280 | 256,179,846 | (60,191) | (262,853,812) | (3,981) | (6,302,718) |
| Balance, shares at Dec. 31, 2025 | 956,985 | 14,183,315 | 420,279,879 | |||||
| Issuance of common stock of majority-owned subsidiary | 66,767 | 8,233 | 75,000 | |||||
| Conversion of 2025 Notes to Series D-1 Preferred Stock | $ 172 | 491,329 | 491,501 | |||||
| Conversion of 2025 Notes to Series D-1 Preferred Stock, shares | 171,735 | |||||||
| Stock-based compensation: | ||||||||
| Amortization of stock options | 306,051 | 306,051 | ||||||
| Net loss | (1,290,454) | (10,495) | (1,300,949) | |||||
| Other comprehensive income | 285 | 285 | ||||||
| Balance at Mar. 31, 2026 | $ 957 | $ 14,355 | $ 420,280 | 257,043,993 | (59,906) | (264,144,266) | (6,243) | (6,730,830) |
| Balance, shares at Mar. 31, 2026 | 956,985 | 14,355,050 | 420,279,879 | |||||
| Balance at Dec. 31, 2025 | $ 957 | $ 14,183 | $ 420,280 | 256,179,846 | (60,191) | (262,853,812) | (3,981) | (6,302,718) |
| Balance, shares at Dec. 31, 2025 | 956,985 | 14,183,315 | 420,279,879 | |||||
| Stock-based compensation: | ||||||||
| Net loss | (2,289,665) | |||||||
| Balance at Jun. 30, 2026 | $ 957 | $ 14,748 | $ 420,280 | 258,475,479 | (59,803) | (265,126,832) | (12,393) | (6,287,564) |
| Balance, shares at Jun. 30, 2026 | 956,985 | 14,748,463 | 420,279,879 | |||||
| Balance at Mar. 31, 2026 | $ 957 | $ 14,355 | $ 420,280 | 257,043,993 | (59,906) | (264,144,266) | (6,243) | (6,730,830) |
| Balance, shares at Mar. 31, 2026 | 956,985 | 14,355,050 | 420,279,879 | |||||
| Conversion of 2025 Notes to Series D-1 Preferred Stock | $ 204 | 583,230 | 583,434 | |||||
| Conversion of 2025 Notes to Series D-1 Preferred Stock, shares | 203,859 | |||||||
| Stock-based compensation: | ||||||||
| Amortization of stock options | 305,944 | 305,944 | ||||||
| Net loss | (982,566) | (6,150) | (988,716) | |||||
| Other comprehensive income | 103 | 103 | ||||||
| Conversion of accrued directors’ fees to Series D-1 Preferred Stock | $ 189 | 542,312 | 542,501 | |||||
| Series D-1 Preferred Stock converted to Common Stock, shares | 189,554 | |||||||
| Balance at Jun. 30, 2026 | $ 957 | $ 14,748 | $ 420,280 | $ 258,475,479 | $ (59,803) | $ (265,126,832) | $ (12,393) | $ (6,287,564) |
| Balance, shares at Jun. 30, 2026 | 956,985 | 14,748,463 | 420,279,879 |
| X | ||||||||||
- Definition Stock issued during period shares conversion of series D one common stock. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period shares conversion of series D one preferred stock. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period value conversion of series D one common stock. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period value conversion of series D one preferred stock. No definition available.
|
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|